JAROD MARCOTTE: Open Payments
NPI 1093783599 · LEAVENWORTH, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,286 in 131 payments from 27 companies in 2025. Trend: 2023 $1,873 · 2024 $2,089 · 2025 $2,286
Food & beverage: $2,286
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $255 |
| ABBVIE INC. | 21 | $243 |
| PFIZER INC. | 21 | $243 |
| AstraZeneca Pharmaceuticals LP | 6 | $222 |
| Lilly USA, LLC | 8 | $168 |
| Novartis Pharmaceuticals Corporation | 8 | $135 |
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
| Astellas Pharma US Inc | 3 | $91 |
| Abbott Laboratories | 4 | $91 |
| GlaxoSmithKline, LLC. | 5 | $89 |
Products named: LEQVIO, UBRELVY, BREZTRI, MOUNJARO, JARDIANCE, ELIQUIS, Wegovy, QULIPTA.
Industry payments across KS — which companies pay providers there.
